Skip to main content Skip to main navigation menu Skip to site footer

Kawasaki disease in an infant: a case report

  • Jesslyn Norberta ,
  • Muhammad Ali ,
  • King Chandra ,


Background: Kawasaki disease is an acute systemic vasculitis of childhood, with a predilection of the main coronary artery. This disease is the most frequent cause of acquired heart disease in developed countries. This report is aimed to describe the diagnosis and treatment of Kawasaki disease in an infant.

Case description: A 4-month-old boy came to the emergency room on November 21, 2021, with a chief complaint of high fever for three days. His appetite has decreased since he got sick. Other complaints, such as red eyes, red lips and red rashes overall his body, occurred two days before the admission. Physical examination: the child's nutritional status was good, with bilateral non-purulent conjunctivitis, erythema and cracked lips, and polymorphous rash on the body, back, and legs. We found enlarged cervical lymph nodes and reactivation of Bacillus Calmette-Guerin (BCG) scars. The laboratory findings were as follows:  HGB  10.6gr/dL, WBC 11.570/µL, PLT 335.000/µL, CRP 84mg/dL, Antigen NS-1 dengue test negative, and SARS-COV2 Antigen test negative. The echocardiography results were minimal pericardial effusion and normal coronary size. With a Harada score of 4, he was diagnosed with Kawasaki disease. Management of the patient includes breastfeeding, infusion of dextrose 5% with sodium chloride (Na Cl) 0.22%, Paracetamol infusion, Intravenous Immunoglobulin (IVIg) single dose, and Acetylsalicylic acid orally. After being discharged from the hospital, he was advised to control his condition routinely to a pediatrician.

Conclusion: Kawasaki disease has been reported in a 4-month-old boy with typical clinical manifestations and successfully treated with good results.


  1. Son MBF, Newburger JW. Kawasaki Disease. Pediatrics in Review. February 2018;36:2. Available from: 10.1542/pir.2016-0182
  2. Kamleshun R, Stephanie MG. Kawasaki disease: a comprehensive review. Arch Med Sci Atheroscler Dis. 2018;3:e41-e45. Available from: 10.5114/amsad.2018.74522
  3. Saputro AS and Syamlan R. Intravenous Immunoglobulin Therapy For Kawasaki Disease (Case report). Jurnal Darma Agung. 2023;31(3):276-83. Available from :
  4. Kwon Y-C, Kim J-J, Yun SW, Yu JJ, Yoon KL, Lee K-Y, et al. Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease. PLoS ONE. 2017; 12(9): e0184248. Available from:
  5. Phamduy TT, Smith S, Herbst KW, Phamduy PT, Brimacombe M, Hogan AH, et al. Kawasaki Disease Hospitalizations in the United States 2016–2020: A Comparison of Before and During the Coronavirus Disease 2019 Era. Pediatr Infect Dis J. 2021;40:e407–e412. Available from: 10.1097/INF.0000000000003289
  6. Singh S, Agarwal S, Bhattad S, Gupta A, Suri S, Rawat A, et al. Kawasaki disease in infants below 6 months: a clinical conundrum?. International Journal of Rheumatic Diseases. 2016. Available from: 10.1111/1756-185X.12854
  7. Yolanda N. Panduan Diagnosis dan Terapi Kawasaki Disease. CDK-232. 2015;42:9.
  8. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu M-H, Saji TT, Pahl E; on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; and Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–e999. Available from: 10.1161/CIR.0000000000000484.
  9. Saguil A, Fargo M, Grogan S. Diagnosis and Management of Kawasaki Disease. American Family Physician. March 2015;91(6):365-371.
  10. Son MBH, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, et al. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores. J Am Heart Assoc. 2017;6:e005378. Available from: 10.1161/JAHA.116.005378.
  11. Idris I, Awadelkarim AM, Saad E, Dayco J, Beker S. Incomplete Kawasaki Disease in an Infant: A Case Report and Literature Review. Cureus. 2022; 14(2): e22122. Available from: 10.7759/cureus.22122
  12. Saleh AA. Kawasaki Disease: A Case Report. International Journal of Contemporary Medical Research. June 2016;3(6):1809-1810.
  13. Haftel HM. Kawasaki Disease. In Kliegman RM, Marchdante KJ, editors. Nelson Essentials of Pediatrics. 8th ed. Philadelphia; Elsevier Inc: 2019.p347-49.
  14. Akca UK, Aydin EA, Aykan HH, Serin O, Sag E, Demir S, et al. Comparison of IVIG resistance predictive models in Kawasaki disease. Pediatr Res. 2022; 91, 621–626. Available from: 10.1038/s41390-021-01459-w.
  15. Sakulchit T, Benseler SM, Goldman RD. Acetylsalicylic acid for children with Kawasaki disease. Child Health Updates, Canadian Family Physician. 2017;63:607-609.
  16. Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, et al. Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. JAMA Pediatrics. December 2016;170:12. Available from: 10.1001/jamapediatrics.2016.2055

How to Cite

Norberta, J., Muhammad Ali, & Chandra, K. (2023). Kawasaki disease in an infant: a case report. Intisari Sains Medis, 14(3), 1161–1164.




Search Panel